Microbira -MAAP-IR

Microbira created an Artificial Intelligence-driven solution to microorganism identification (MAAP-IR). This infrared, internet-based solution achieves rapid identification of microorganisms directly from positive blood and microorganism cultures

– Can identify microorganisms in <5 minutes from initial culture.]
– Identifies Yeasts, Gram-negative & positive bacteria without Gram staining
– Is sensitive for serotyping salmonella and non-O157 E. coli from E. coli O157:H7
– Major opportunity to assist healthcare needs in developing countries as our technology is low cost and accessible using the internet reducing the significant barriers to entry in resource-limited settings.
– UKCA IVD medical device certified
-No disposables

  • Antimicrobial stewardship
  • Microbial diagnostics
  • Infection prevention
  • Antimicrobial compound/strategy
  • Removal antibiotics/bacteria

  • Bacteria
  • Fungi
  • Yeasts
  • Viruses
  • Parasites

  • Human
  • Veterinary
  • AgriFood
  • Environmental
  • Other

Development stage:
  • Validation
  • Market entry
  • Research
  • Development
  • Marketed product

  • Company
  • Academia
  • Institute
  • NGO
  • Government

  • License
  • Co-develop
  • Outsource
  • Joint Venture
  • Sell

Funding organisation:
  • OTHER / NA
  • CARB-X
  • FIND

Infectious disease area:
  • UTI
  • STI
  • BSI
  • RTI
  • GII
  • SSTI
  • CNSI
  • IAI
  • SSI

Geographic origin:
  • Eurasia
  • North America
  • South America
  • Africa
  • Oceania

Placement of MAAP-IR in labs for pilot studies and to expand our existing network.

Microbira Ltd is a UK-based, limited company which has created the Microbira Advanced Analytical Platform-Infrared (MAAP-IR) -a cloud-based innovative software solution leveraging artificial intelligence (AI) coupled with spectroscopy. The technology fits all size laboratories and represents a paradigm shift in microorganism identification-rapid, universally applicable, cost-effective and sustainable identifications. MAAP-IR is applicable to clinical microbiology, veterinary pathology, the food industry, and the environment. This infrared, internet-based solution achieves rapid identification of microorganisms directly from microorganism cultures and positive blood cultures, enhancing patient care and potentially reducing antimicrobial resistance.
Across a group of 38 species, our technology has demonstrated an average 99% success rate for Gram identification, an average 92% success rate for correct genus identification, and an 84% success rate for species-level identification.

Tailored prediction models for research use .MAAP-IR ‘s versatility enables Microbira to create prediction models for our clients.
Specific models will be available for veterinary and food pathogens during 2024.

Microbira is piloting a method of microorganism identification directly from positive blood cultures. This is vital for bloodstream infections and critical care patients, with a 20-minute sample prep leading to rapid results.

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed